Search for: "Bayer Corp" Results 201 - 220 of 505
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Groundhog Day in Illinois in June
19 Jun 2012, 1:36 pm by Michelle Yeary
Bayer Corp., 643 F.3d 994 (7th Cir. 2011). [read post]
Drug and Device Law - http://druganddevicelaw.blogspot.com/
Groundhog Day in Illinois in June
19 Jun 2012, 1:36 pm by Michelle Yeary
Bayer Corp., 643 F.3d 994 (7th Cir. 2011). [read post]
Drug and Device Law - http://druganddevicelaw.blogspot.com/
Groundhog Day in Illinois in June
19 Jun 2012, 1:36 pm by Michelle Yeary
Bayer Corp., 643 F.3d 994 (7th Cir. 2011). [read post]
Drug and Device Law - http://druganddevicelaw.blogspot.com/
When Should The Statute Of Limitations Run For Medication Lawsuits?
24 May 2012, 4:23 am by Max Kennerly, Esq.
Corp., 570 F.2d 1168, 1174 (3d Cir.1978)(“If the bar is not apparent on the face of the complaint, then it may not afford the basis for a dismissal of the complaint under Rule 12(b)(6). [read post]
Litigation and Trial - Max Kennerly - http://www.litigationandtrial.com/
Seventh Circuit Reluctantly Opens The Door For Copy-Cat Class Action Suits
6 May 2012, 4:42 pm by Seyfarth Shaw LLP
Bayer Corp., 131 S. [read post]
Workplace Class Action Blog - http://www.workplaceclassaction.com/
Bayer Signs DLA Piper to Lobby on Building Standards Issues
24 Apr 2012, 12:55 pm by Andrew Ramonas
Williams received $30,000 for its work for Bayer Corp. during that period. [read post]
The BLT: Blog of Legal Times - http://legaltimes.typepad.com/blt/
Court again finds that Exergen, and not Therasense, provides standard for pleading inequitable conduct.
23 Apr 2012, 10:16 am by James L. Higgins
Bayer Cropscience AG v. [read post]
Delaware IP Law Blog - http://www.delawareiplaw.com/
Mass Action Is Beyond The Mere 'Number Game'
17 Apr 2012, 4:30 am
Bayer Corp., 610 F.3d 390, 393 (7th Cir. 2010) and Tanoh v. [read post]
Class Action Fairness Act Blog - http://www.cafalawblog.com/
Exergen, Not Therasense, Governs Pleading Standard for Inequitable Conduct
16 Apr 2012, 6:07 am by The Docket Navigator
" Bayer CropScience AG v. [read post]
Docket Report Patent Infringement Blog - http://docketreport.blogspot.com/
Becton Dickinson loses CAFC appeal on trademark on design of a closure cap for blood collection tubes
12 Apr 2012, 10:11 am by Lawrence B. Ebert
In re Bayer Aktiengesellschaft, 488 F.3d 960, 970 (Fed. [read post]
IPBiz - http://ipbiz.blogspot.com/
Collateral estoppel in class action cases: Bridgeford v. Pacific Health Corp.
10 Apr 2012, 5:00 am by Kimberly A. Kralowec
Bayer Corp., 131 S.Ct. 2368 (2011), handed down in June. [read post]
The UCL Practitioner - http://www.uclpractitioner.com/
Chamber of Commerce loses trademark appeal at CAFC
4 Apr 2012, 8:53 am by Lawrence B. Ebert
” In re Bayer Aktiengesellschaft, 488 F.3d 960, 963 (Fed. [read post]
IPBiz - http://ipbiz.blogspot.com/
Pieczenik v. Bayer Corp. (Fed. Cir. 2012)
2 Apr 2012, 9:59 pm by Patent Docs
By Donald Zuhn -- Last month, the Federal Circuit affirmed a decision by the District Court for the District of New Jersey dismissing Plaintiff-Appellant Dr. [read post]
Patent Docs - http://www.patentdocs.org/
The Uses of the Named Plaintiff Deposition II - Burns v. Bayer Corp. (S.D. Ill. 2012)
20 Mar 2012, 3:42 am by Andrew Trask
Bayer Corp., 2012 U.S. [read post]
Class Action Countermeasures - http://www.classactioncountermeasures.com
India Compsulory License Update: Blowback Edition
17 Mar 2012, 3:24 pm by Stephen Jenei
  In India, Bayer Corp. markets sorefinib as Nexavar for about $5,600 a month under a patent in force until 2021. [read post]
Patent Baristas - http://www.patentbaristas.com
The Anatomy of a Compulsory License: Natco Pharma Ltd. v. Bayer Corp. (Indian Patent Office)
15 Mar 2012, 9:59 pm by Patent Docs
He helpfully sent along the decision granting a compulsory license to Natco for Bayer's anticancer drug, sorafenib tosylate (sold as Nexavar®). [read post]
Patent Docs - http://www.patentdocs.org/
India Issues Compulsory License for Bayer Drug Because the Price Was Too High
15 Mar 2012, 10:40 am by Stephen Jenei
In India, Bayer Corp. markets sorefinib as Nexavar for about $5,600 a month under a patent in force until 2021. [read post]
Patent Baristas - http://www.patentbaristas.com
IP Address Blog Updates for March 14, 2012
14 Mar 2012, 6:14 am by Lorraine Fleck
Intellectual property news on Bayer, Apple, Trademarks Filing Numbers News Corp, Allergan http://bloom.bg/A5uLK8 I agree | Never “Pin” A Photo On Pinterest That You Don’t Own http://read.bi/xHGHDh The Scarily Simple Techniques Used to Make Counterfeit Wine http://buswk.co/wsEd6x Adventures in Copyright? [read post]
IP Address - http://ipaddress.wordpress.com
Johns v. Bayer: Certifying Class and Affirming Presumption of Reliance by “Reasonable Consumer”
12 Mar 2012, 1:53 am by webmaster
Bayer Corp., 09-cv-1935, 2012 U.S. [read post]
Impact Litigation Journal - http://impactlitigation.com/
Parisian Transcripts 2.0
2 Mar 2012, 6:52 am by Bexis
Bayer (Baycol) Trial2005-01-21 Hardy v. [read post]
Drug and Device Law - http://druganddevicelaw.blogspot.com/